Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease?

B. Oktay, S. Ardic (Ankara, Turkey)

Source: Annual Congress 2008 - Structural remodelling in COPD
Session: Structural remodelling in COPD
Session type: Thematic Poster Session
Number: 695
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Oktay, S. Ardic (Ankara, Turkey). Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease?. Eur Respir J 2008; 32: Suppl. 52, 695

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 52S-63S
Year: 2003



Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 459s
Year: 2004

Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010

Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease?
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Association between endothelial dysfunction and nutrient consumption in patients with chronic obstructive pulmonary disease and heart failure.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018


The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary disease and severe bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease?
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007


Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2011 - COPD management
Year: 2011


Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019

The frequency of the cardiac arrhythmias of the patients who suffer from the chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

Protein metabolism in chronic respiratory disease
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=23
Year: 2003

Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012


Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009